Basel Statements revised
September 28, 2015
GLOBAL standards of practice
used by hospital pharmacists
around the world, known as the
‘Basel Statements,’ have been
revised by the Hospital Pharmacy
Section of the International
Pharmaceutical Federation.
FIP said the revision reflects the
“rapid development of hospital
pharmacy practice and the most
current evidence,” in order to
continue to encourage practice
development across the world.
First published by the FIP’s
Hospital Pharmacy Section (HPS)
in 2009 the Basel Statements
cover six main areas of hospital
pharmacy: procurement, influences
on prescribing, preparation and
delivery of medicines, medicines
administration, monitoring
medication, and human resources
& training.
“There are several totally new
statements, many of them dealing
with advances in information
technology and the importance of
pharmacists using electronic health
records to improve the quality of
medicines use,” said HPS secretary,
Lee Vermeulen.
Significant changes have also
been made to reflect FIP’s definition
of ‘responsible use of medicines’
adopted in 2012, and the joint
FIP-World Health Organization
Guidelines on Good Pharmacy
Practice, Vermeulen added.
The wording has also been
simplified to make them clearer
and more easily applicable, with
the revision process involving a
“consensus exercise” which collated
the opinions and experience of
hundreds of hospital pharmacists
from across the globe.
“The result is an authoritative
resource that reflects ideal
practices for hospital pharmacy
worldwide,” Vermuelen said.
“We believe that the statements
provide a key roadmap for hospital
pharmacy practice”.
There are now a total of 65 Basel
statements - to view a video see
pharmacydaily.com.au/videos, and
for more details see fip.org.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Sep 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Sep 15
